News

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Do you ever get to bed and fail to catch some sleep until the wee hours of the morning? For some people, it can go on for days without managing a moment of sleep.In today's fast-paced world, sleepless ...
OSA-related hypoxemia linked to increased frontoparietal cerebrovascular pathology, which is associated with reduced medial temporal lobe integrity.